Table 1: Demographic features and biochemical characteristics of HCC and liver cirrhosis patients.
Characteristics |
HCC Group (N = 40) |
Liver Cirrhosis Group (N = 30) |
P Value |
Age (years) |
60.92 ± 9.01 |
55.53 ± 9.64 |
0.02*
|
Gender Male Female |
31 (77.5%) 9 (22.5%) |
15 (50%) 15 (50%) |
0.02* |
Residence Urban Rural |
25 (62.5%) 15 (37.5%) |
20 (66.67%) 10 (33.33%) |
0.72 |
Occupation Farmer Non- farmer |
14 (35%) 26 (65%) |
4 (13.33%) 26 (86.67%) |
0.04* |
Etiology Smoking Alcohol HCV HBV |
22 (55%) 1 (2.5%) 37 (92.5%) 2 (5%) |
11 (36.67%) 0 (0%) 22 (73.33%) 1 (3.33%) |
0.13 1 0.04* 1 |
ALT (IU) |
34.97 (2.9-160) |
14.8 (19-87) |
0.000* |
AST(IU) |
36.2 (28-137) |
12.7 (24-75) |
0.000* |
ALP (IU) |
174.95 ± 121.36 |
167.17 ± 121.3 |
0.22 |
Total Bilirubin mg/dl |
3.19 (0.6- 63) |
1.95 (0.5- 21) |
0.07 |
Albumin g/dl |
2.62 ± 0.55 |
2.5 ± 0.77 |
0.45 |
PT (seconds) |
17.29 ± 4.54 |
18.69 ± 10.9 |
0.56 |
INR |
1.46 ± 0.31 |
1.6 ± 0.94 |
0.77 |
Creatinine mg/dl |
2.12 ± 1.72 |
1.73 ± 1.3 |
0.33 |
SD: Standard deviation; HCC: hepatocellular carcinoma; MELD: Model for end stage liver disease; uMELD: updated MELD.
Data are presented as mean ± standard deviation or median with minimum and maximum values, as appropriate. HCC: hepatocellular carcinoma; HCV: Hepatitis c virus; HBV: Hepatitis B virus; ALT:Alanine aminotransferase; AST:aspartate aminotransferase; ALP:alkaline phosphatase; PT:prothrombin time; INR:international normalized ratio *:Values statistically significant (at P< 0.05).